Glioblastoma multiforme surgery

Jump to navigation Jump to search

Glioblastoma multiforme Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glioblastoma multiforme from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glioblastoma multiforme surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glioblastoma multiforme surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glioblastoma multiforme surgery

CDC on Glioblastoma multiforme surgery

Glioblastoma multiforme surgery in the news

Blogs on Glioblastoma multiforme surgery

Directions to Hospitals Treating Glioblastoma multiforme

Risk calculators and risk factors for Glioblastoma multiforme surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Surgery is the mainstay of treatment for glioblastoma multiforme. The aim of surgery is to Make a definitive diagnosis. Debulk the tumor to relieve elevated intracranial pressure, reduce the tumor mass as a precursor to adjuvant treatment. Removal of 98% or more of the tumor has been associated with a better prognosis. using an intraoperative imaging control could increase the aggressiveness of the surgical procedure[1]

Surgery

1. Surgery is the mainstay of treatment for glioblastoma multiforme.[1]

  • The aim of surgery is to:
    • Make a definitive diagnosis
    • Debulk the tumor to relieve elevated intracranial pressure
    • Reduce the tumor mass as a precursor to adjuvant treatment
  • Removal of 98% or more of the tumor has been associated with a better prognosis.
  • The chances of near-complete initial removal of the tumor can be greatly increased if the surgery is guided by a fluorescent dye known as 5-aminolevulinic acid.
  • Glioblastoma multiforme tumor cells are widely infiltrative through the brain at diagnosis. Despite a near-total resection, majority of people with glioblastoma multiforme develop recurrence, either at the original site or at distant satellite lesions within the brain.

2. CSF shunting is performed to relieve the pressure in the brain due to blockade in the flow of cerebrospinal fluid by the tumor.

  • External ventricular drain
    • Temporary shunt
  • Internal drain
    • Permanent shunt
    • Drains CSF into the patient’s abdomen, where it is absorbed into the body

Indication for using intra-operative MRI

  • the best indication for using an ioMRI appears to be when a GTR/NTR resection seems preoperatively possible associated with a low permanent morbidity.
  • Three factors should play a major role:
  1. the tumor location at distance from an eloquent area
  2. the surgeon's experience
  3. the patient desire

References

  1. 1.0 1.1 Treatment of glioblastoma multiforme. Dr Dylan Kurda and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/glioblastoma


Template:WikiDoc Sources